Literature DB >> 8248477

Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury.

J P Geraci1, M S Mariano.   

Abstract

Cellular changes that occur within the liver before and during liver fibrosis have been studied. At various times (0-90 days) after gamma irradiation (0-25 Gy) of the whole liver, hepatocytes and liver nonparenchymal cells were isolated by enzymatic dissociation of the liver and differential centrifugation. Differential cell counts were done to quantify the yield of hepatocytes and nonparenchymal cells. Hepatocyte function in vitro was assayed by the uptake of rose bengal and compared with the clearance of the dye in vivo. Intracellular alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were used to estimate the effect of radiation on the phenotypic expression of hepatocytes. Gene expression of transforming growth factor beta 1 (TGF-beta 1), a cytokine which has been found to play a role in hepatic fibrosis, was measured by 32P-cDNA:mRNA hybridization of poly(A+) mRNA isolated from purified populations of hepatocytes and nonparenchymal cells. Morphologically, hemorrhages were evident in perfused livers 28 days after 25 Gy whole-liver irradiation. This injury was preceded by a significant increase in liver nonparenchymal cells at 2 weeks, the earliest time after irradiation at which measurements were made. Significant increases in liver nonparenchymal cells occurred at doses greater than 10 Gy and persisted throughout the follow-up period after irradiation. The lowest dose studied (5 Gy) inhibited both normal growth of the liver and the associated increase in the number of hepatocytes. Doses greater than 10 Gy resulted in a dose-dependent decline in liver mass and hepatocytes. Viable hepatocytes isolated from irradiated dysfunctional livers, with respect to clearance of rose bengal, were functionally normal in vitro. A dose-dependent decline in the ALT and AST contents of liver cell suspensions and homogenates was observed but the relative decline in ALT was greater, resulting in lower ALT/AST ratios. This decline in the ALT/AST ratios occurred at doses (< 15 Gy) which caused no loss of hepatocytes, suggesting possible conversion of ALT-rich periportal hepatocytes to ALT-poor hepatocytes due to changes in the microenvironment and/or aging of the cell population. TGF-beta 1 mRNA was detected mainly in nonparenchymal cells, and radiation preferentially enhanced the TGF-beta 1 gene expression in these cells. These data suggest that radiation-induced alterations in liver nonparenchymal cell populations may be responsible for microvascular fibrosis, which results in a cascade of pathological events which lead to hepatocyte loss.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8248477

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  12 in total

Review 1.  Liver repopulation and carcinogenesis: two sides of the same coin?

Authors:  Fabio Marongiu; Silvia Doratiotto; Stefania Montisci; Paolo Pani; Ezio Laconi
Journal:  Am J Pathol       Date:  2008-03-05       Impact factor: 4.307

2.  Dietary selenium for the mitigation of radiation injury: effects of selenium dose escalation and timing of supplementation.

Authors:  Fritz Sieber; Sarah A Muir; Eric P Cohen; Brian L Fish; Marylou Mäder; Ashley M Schock; Bryan J Althouse; John E Moulder
Journal:  Radiat Res       Date:  2011-07-08       Impact factor: 2.841

3.  Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.

Authors:  Chau-Hua Chi; I-Li Liu; Wei-Yu Lo; Bor-Song Liaw; Yu-Shan Wang; Kwan-Hwa Chi
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

4.  Hepatic proliferation after partial liver irradiation in Sprague-Dawley rats.

Authors:  Zhi-Gang Ren; Jian-Dong Zhao; Ke Gu; Jian Wang; Guo-Liang Jiang
Journal:  Mol Biol Rep       Date:  2011-07-16       Impact factor: 2.316

5.  10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model.

Authors:  John E Baker; Brian L Fish; Jidong Su; Steven T Haworth; Jennifer L Strande; Richard A Komorowski; Raymond Q Migrino; Anil Doppalapudi; Leanne Harmann; X Allen Li; John W Hopewell; John E Moulder
Journal:  Int J Radiat Biol       Date:  2009-12       Impact factor: 2.694

6.  Cardiac injury after 10 gy total body irradiation: indirect role of effects on abdominal organs.

Authors:  Marek Lenarczyk; Vy Lam; Eric Jensen; Brian L Fish; Jidong Su; Stacy Koprowski; Richard A Komorowski; Leanne Harmann; Raymond Q Migrino; X Allen Li; John W Hopewell; John E Moulder; John E Baker
Journal:  Radiat Res       Date:  2013-08-06       Impact factor: 2.841

7.  Quantitative in vivo assessment of radiation injury of the liver using Gd-EOB-DTPA enhanced MRI: tolerance dose of small liver volumes.

Authors:  Max Seidensticker; Ricarda Seidensticker; Konrad Mohnike; Christian Wybranski; Thomas Kalinski; Sebastian Luess; Maciej Pech; Peter Wust; Jens Ricke
Journal:  Radiat Oncol       Date:  2011-04-17       Impact factor: 3.481

8.  Evidence for modulation of pericryptal sheath myofibroblasts in rat descending colon by transforming growth factor beta and angiotensin II.

Authors:  Jay R Thiagarajah; Nina M Griffiths; Kevin C Pedley; Richard J Naftalin
Journal:  BMC Gastroenterol       Date:  2002-02-12       Impact factor: 3.067

9.  Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.

Authors:  Masumi Imaeda; Hitoshi Ishikawa; Yukari Yoshida; Takeo Takahashi; Yu Ohkubo; Atsushi Musha; Mayumi Komachi; Yoichi Nakazato; Takashi Nakano
Journal:  J Radiat Res       Date:  2014-02-23       Impact factor: 2.724

10.  Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity.

Authors:  Max Seidensticker; Ricarda Seidensticker; Robert Damm; Konrad Mohnike; Maciej Pech; Bruno Sangro; Peter Hass; Peter Wust; Siegfried Kropf; Günther Gademann; Jens Ricke
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.